CIK 0001557746 · Non-accelerated filer<br>Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460571712
- Phone
- 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-03 | Balthaser Kevin Chief Financial Officer | Grant or award · Restricted Stock Units | +88,100 | 88,100 | ||
| 2025-02-03 | Balthaser Kevin Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +308,200 | 308,200 | ||
| 2025-02-03 | Loerop James Chief Business Officer | Grant or award · Restricted Stock Units | +83,500 | 83,500 | ||
| 2025-02-03 | Loerop James Chief Business Officer | Grant or award · Employee Stock Option (Right to Buy) | +292,300 | 292,300 | ||
| 2025-02-01 | Loerop James Chief Business Officer | Shares withheld for taxes | −15,980 | $2.48 | $40K | 102,773 |
| 2025-02-01 | Loerop James Chief Business Officer | Shares withheld for taxes | −15,980 | $2.48 | $40K | 102,773 |
| 2025-02-01 | Walker Neal INTERIM CEO | Option exercise | +9,467 | 1,464,277 | ||
| 2025-02-01 | Walker Neal INTERIM CEO | Shares withheld for taxes | −3,559 | $2.48 | $9K | 1,460,718 |
| 2025-02-01 | Walker Neal INTERIM CEO | Option exercise · Restricted Stock Units | −9,467 | 28,400 | ||
| 2025-02-01 | Monahan Joseph Chief Scientific Officer | Option exercise | +7,500 | 228,562 | ||
| 2025-02-01 | Monahan Joseph Chief Scientific Officer | Option exercise | +14,750 | 243,312 | ||
| 2025-02-01 | Monahan Joseph Chief Scientific Officer | Shares withheld for taxes | −11,317 | $2.48 | $28K | 231,995 |
| 2025-02-01 | Monahan Joseph Chief Scientific Officer | Option exercise · Restricted Stock Units | −7,500 | 15,000 | ||
| 2025-02-01 | Monahan Joseph Chief Scientific Officer | Option exercise · Restricted Stock Units | −14,750 | 44,250 | ||
| 2025-02-01 | Balthaser Kevin Chief Financial Officer | Option exercise | +14,750 | 95,676 | ||
| 2025-02-01 | Balthaser Kevin Chief Financial Officer | Shares withheld for taxes | −5,816 | $2.48 | $14K | 89,860 |
| 2025-02-01 | Balthaser Kevin Chief Financial Officer | Option exercise · Restricted Stock Units | −14,750 | 44,250 | ||
| 2025-02-01 | Loerop James Chief Business Officer | Option exercise | +11,250 | 96,503 | ||
| 2025-02-01 | Loerop James Chief Business Officer | Option exercise | +7,500 | 104,003 | ||
| 2025-02-01 | Loerop James Chief Business Officer | Option exercise | +14,750 | 118,753 |
Page 8 of 34 · 680 trades